Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $9.36 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 50.13.
Market Cap
9.36T
Revenue
4.66T
Profits
186.64B
PE Ratio
50.13
Profit Margin
4.00%
Dividend Yield
0.38%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.09T | 3.60% | 2,509,057 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 653.35B | 3.33% | 7,838,158 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 457.54B | 3.43% | 5,010,229 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 353.59B | -0.43% | 3,605,083 | 450.53B |
| 5 | MRK | Merck & Co., Inc. | 333.49B | -0.59% | 10,284,238 | 66.57B |
| 6 | NVS | Novartis AG | 293.68B | 1.70% | 1,412,922 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 247.93B | 2.05% | 3,001,598 | 61.37B |
| 8 | AMGN | Amgen Inc. | 229.92B | 1.41% | 2,591,636 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 217.80B | 0.60% | 1,721,605 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 202.99B | 1.85% | 12,089,921 | 50.34B |
| 11 | ABT | Abbott Laboratories | 194.98B | 2.09% | 9,781,754 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 177.86B | 3.25% | 5,758,846 | 30.46B |
| 13 | PFE | Pfizer Inc. | 155.32B | 1.41% | 34,660,086 | 63.70B |
| 14 | DHR | Danaher Corporation | 140.30B | -1.51% | 2,290,001 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 138.20B | 0.22% | 2,384,988 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 134.92B | 2.20% | 9,413,982 | 49.19B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 133.88B | 2.45% | 1,497,081 | 12.59B |
| 18 | SYK | Stryker Corporation | 127.10B | -0.09% | 3,179,934 | 25.84B |
| 19 | CVS | CVS Health Corporation | 121.39B | 0.96% | 6,855,122 | 412.65B |
| 20 | MDT | Medtronic plc | 117.87B | 1.64% | 6,790,311 | 36.36B |
| 21 | SNY | Sanofi | 107.74B | 1.26% | 3,171,098 | 55.89B |
| 22 | GSK | GSK plc | 102.43B | 1.73% | 2,828,981 | 44.05B |
| 23 | MCK | McKesson Corporation | 101.35B | 1.09% | 618,721 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 89.14B | 1.67% | 1,450,017 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.37B | 2.06% | 950,870 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.91B | 0.65% | 779,073 | 15.53B |
| 27 | CI | The Cigna Group | 73.59B | 1.15% | 920,790 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 73.14B | -1.87% | 11,724,273 | 21.00B |
| 29 | ARGX | argenx SE | 62.99B | 0.52% | 333,939 | 5.32B |
| 30 | COR | Cencora, Inc. | 60.33B | 1.16% | 1,032,060 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 57.04B | 3.86% | 3,809,695 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 54.65B | -0.29% | 1,792,653 | 254.25B |
| 33 | EW | Edwards Lifesciences Corporation | 52.44B | 0.19% | 2,762,349 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 49.24B | -0.72% | 1,616,423 | 22.48B |
| 35 | RVMD | Revolution Medicines, Inc. | 46.30B | 1.89% | 1,651,904 | - |
| 36 | HUM | Humana Inc. | 45.87B | -0.60% | 741,195 | 145.68B |
| 37 | NTRA | Natera, Inc. | 44.93B | -0.79% | 1,132,548 | 2.71B |
| 38 | MDLN | Medline Inc. | 44.86B | -2.18% | 5,783,000 | 29.94B |
| 39 | IDXX | IDEXX Laboratories, Inc. | 43.59B | 1.32% | 570,337 | 4.55B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 42.63B | 0.33% | 6,197,596 | 17.32B |
| 41 | HLN | Haleon plc | 42.41B | 1.46% | 9,481,912 | 14.80B |
| 42 | ONC | BeOne Medicines AG | 41.97B | 1.83% | 613,555 | 6.13B |
| 43 | A | Agilent Technologies, Inc. | 41.92B | -0.01% | 1,798,436 | 7.23B |
| 44 | IQV | IQVIA Holdings Inc. | 39.51B | -0.50% | 1,095,592 | 16.98B |
| 45 | VEEV | Veeva Systems Inc. | 39.43B | 1.85% | 1,522,561 | 3.32B |
| 46 | WAT | Waters Corporation | 39.42B | -1.59% | 739,738 | 4.64B |
| 47 | ALC | Alcon Inc. | 35.89B | 1.46% | 1,562,091 | 10.86B |
| 48 | RPRX | Royalty Pharma plc | 34.32B | 0.40% | 2,075,199 | 2.54B |
| 49 | DXCM | DexCom, Inc. | 33.81B | 0.95% | 3,363,036 | 4.97B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 32.81B | 0.36% | 3,317,000 | 21.27B |
| 51 | CNC | Centene Corporation | 32.22B | 1.26% | 3,410,501 | 180.30B |
| 52 | RMD | ResMed Inc. | 31.73B | -0.18% | 1,295,889 | 5.65B |
| 53 | BIIB | Biogen Inc. | 31.41B | 1.63% | 694,010 | 10.03B |
| 54 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.59B | 1.79% | 1,600,400 | 4.80B |
| 55 | ZTS | Zoetis Inc. | 30.56B | 1.36% | 4,028,430 | 9.53B |
| 56 | ILMN | Illumina, Inc. | 28.43B | -2.51% | 1,192,959 | 4.49B |
| 57 | INSM | Insmed Incorporated | 28.05B | 0.11% | 1,274,119 | 1.14B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.04B | -1.25% | 140,587 | 4.13B |
| 59 | ROIV | Roivant Sciences Ltd. | 26.99B | 3.12% | 6,411,101 | 7.53M |
| 60 | PHG | Koninklijke Philips N.V. | 26.58B | 1.04% | 702,684 | 20.18B |
| 61 | LH | Labcorp Holdings Inc. | 26.13B | -0.36% | 588,859 | 14.35B |
| 62 | DGX | Quest Diagnostics Incorporated | 26.08B | 0.31% | 693,609 | 11.56B |
| 63 | MRNA | Moderna, Inc. | 25.14B | -2.33% | 4,304,996 | 2.23B |
| 64 | INCY | Incyte Corporation | 25.03B | -0.02% | 1,191,481 | 5.82B |
| 65 | WST | West Pharmaceutical Services, Inc. | 24.39B | -0.01% | 274,254 | 3.33B |
| 66 | BNTX | BioNTech SE | 23.30B | 1.26% | 921,586 | 3.03B |
| 67 | STE | STERIS plc | 22.66B | 1.15% | 657,929 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 22.23B | 1.93% | 366,432 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.76B | 2.14% | 636,140 | 21.81B |
| 70 | GH | Guardant Health, Inc. | 21.49B | -0.96% | 1,202,372 | 1.18B |
| 71 | GMAB | Genmab A/S | 19.45B | 0.37% | 2,706,951 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.91B | 0.97% | 1,207,170 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.57B | -0.37% | 9,049,178 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.48B | -1.14% | 131,427 | 2.78B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 16.43B | 1.90% | 459,255 | 4.60B |
| 76 | ASND | Ascendis Pharma A/S | 16.34B | 0.59% | 452,633 | 1.20B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 16.22B | 3.87% | 2,718,343 | 713.07M |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.68B | -0.17% | 1,037,564 | 3.37B |
| 79 | SOLV | Solventum Corporation | 14.89B | 0.73% | 1,163,063 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.78B | 0.88% | 1,887,130 | 4.23B |
| 81 | BAX | Baxter International Inc. | 13.41B | 0.12% | 6,688,490 | 11.47B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.33B | -2.60% | 703,716 | 4.00B |
| 83 | EXEL | Exelixis, Inc. | 13.16B | 1.53% | 1,290,526 | 2.44B |
| 84 | BMRN | BioMarin Pharmaceutical Inc. | 12.97B | 0.53% | 1,942,498 | 3.41B |
| 85 | ICLR | ICON Public Limited Company | 12.89B | -1.42% | 556,625 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.79B | -0.74% | 176,791 | 1.50B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.77B | 0.79% | 804,025 | 830.81M |
| 88 | RVTY | Revvity, Inc. | 12.69B | -2.08% | 800,026 | 2.91B |
| 89 | SNN | Smith & Nephew plc | 12.65B | 1.72% | 682,934 | 6.30B |
| 90 | FMS | Fresenius Medical Care AG | 12.50B | 0.26% | 585,813 | 22.19B |
| 91 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.42B | -0.90% | 974,991 | 669.50M |
| 92 | BTSG | BrightSpring Health Services, Inc. | 12.40B | -1.46% | 1,785,396 | 14.37B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.12B | -0.10% | 356,198 | 1.28B |
| 94 | EHC | Encompass Health Corporation | 12.05B | 0.09% | 1,087,712 | 6.21B |
| 95 | ALGN | Align Technology, Inc. | 11.93B | -1.90% | 744,753 | 4.14B |
| 96 | HALO | Halozyme Therapeutics, Inc. | 11.90B | 1.83% | 1,955,274 | 1.66B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.81B | 0.13% | 5,083,144 | 5.02B |
| 98 | GMED | Globus Medical, Inc. | 11.61B | 1.55% | 1,170,975 | 3.14B |
| 99 | DVA | DaVita Inc. | 11.35B | 0.68% | 489,530 | 14.01B |
| 100 | AXSM | Axsome Therapeutics, Inc. | 11.30B | -0.27% | 506,353 | 776.57M |
| 101 | TECH | Bio-Techne Corporation | 11.25B | -0.23% | 2,555,531 | 1.22B |
| 102 | GKOS | Glaukos Corporation | 10.86B | -0.79% | 625,626 | 612.84M |
| 103 | MOH | Molina Healthcare, Inc. | 10.61B | 0.27% | 531,024 | 42.47B |
| 104 | CYTK | Cytokinetics, Incorporated | 10.58B | 0.30% | 1,653,100 | 67.67M |
| 105 | ENSG | The Ensign Group, Inc. | 10.55B | 0.53% | 234,495 | 5.49B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 10.33B | -1.74% | 255,847 | 7.46M |
| 107 | ABVX | ABIVAX Société Anonyme | 10.27B | -1.48% | 482,010 | 5.67M |
| 108 | PODD | Insulet Corporation | 10.27B | 5.96% | 1,622,404 | 3.05B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.26B | 0.33% | 3,068,819 | 3.50B |
| 110 | SMMT | Summit Therapeutics Inc. | 10.23B | 0.31% | 4,603,921 | - |
| 111 | UHS | Universal Health Services, Inc. | 10.20B | 1.50% | 939,129 | 18.11B |
| 112 | PTGX | Protagonist Therapeutics, Inc. | 10.18B | -0.81% | 471,648 | 281.99M |
| 113 | APGE | Apogee Therapeutics, Inc. | 10.15B | -0.01% | 992,187 | - |
| 114 | KYMR | Kymera Therapeutics, Inc. | 10.09B | -0.02% | 640,893 | 105.00M |
| 115 | HSIC | Henry Schein, Inc. | 9.94B | -0.32% | 1,029,334 | 13.60B |
| 116 | IONS | Ionis Pharmaceuticals, Inc. | 9.91B | 1.69% | 3,192,641 | 874.09M |
| 117 | KRYS | Krystal Biotech, Inc. | 9.85B | -0.87% | 148,470 | 440.48M |
| 118 | OSCR | Oscar Health, Inc. | 9.64B | -0.86% | 4,296,088 | 15.32B |
| 119 | SYRE | Spyre Therapeutics, Inc. | 9.51B | 3.08% | 949,561 | - |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 9.43B | -0.72% | 210,659 | 2.59B |
| 121 | RGEN | Repligen Corporation | 9.38B | -1.71% | 462,721 | 785.10M |
| 122 | IMVT | Immunovant, Inc. | 9.15B | 1.35% | 1,544,321 | - |
| 123 | AVTR | Avantor, Inc. | 9.02B | -1.26% | 6,310,268 | 6.56B |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | -0.04% | 3,971,945 | 42.16M |
| 125 | TEM | Tempus AI, Inc. | 8.91B | -4.42% | 3,519,969 | 1.43B |
| 126 | PCVX | Vaxcyte, Inc. | 8.90B | -0.71% | 705,939 | - |
| 127 | QGEN | Qiagen N.V. | 8.75B | -0.66% | 2,748,965 | 2.10B |
| 128 | BRKR | Bruker Corporation | 8.66B | -1.40% | 1,553,783 | 3.50B |
| 129 | HQY | HealthEquity, Inc. | 8.59B | 0.45% | 643,109 | 1.34B |
| 130 | ATR | AptarGroup, Inc. | 8.38B | -0.01% | 500,149 | 3.93B |
| 131 | ALKS | Alkermes plc | 8.30B | -0.74% | 970,918 | 1.67B |
| 132 | IBRX | ImmunityBio, Inc. | 8.18B | -2.53% | 5,413,300 | 165.79M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.94B | -0.16% | 447,059 | 239.92M |
| 134 | ORKA | Oruka Therapeutics, Inc. | 7.49B | 0.37% | 574,898 | - |
| 135 | TWST | Twist Bioscience Corporation | 7.28B | -6.68% | 1,299,367 | 431.80M |
| 136 | TXG | 10x Genomics, Inc. | 7.25B | -4.07% | 1,969,714 | 616.91M |
| 137 | TGTX | TG Therapeutics, Inc. | 7.13B | 1.99% | 1,195,008 | 799.54M |
| 138 | HNGE | Hinge Health, Inc. | 7.12B | 0.42% | 1,124,388 | 720.06M |
| 139 | PACS | PACS Group, Inc. | 6.94B | -1.17% | 610,197 | 5.55B |
| 140 | CHE | Chemed Corporation | 6.89B | 0.81% | 115,176 | 2.60B |
| 141 | GRFS | Grifols, S.A. | 6.79B | -0.26% | 274,040 | 8.48B |
| 142 | CGON | CG Oncology, Inc. | 6.76B | -1.06% | 562,499 | 6.23M |
| 143 | SRRK | Scholar Rock Holding Corporation | 6.66B | 5.13% | 1,217,148 | - |
| 144 | LQDA | Liquidia Corporation | 6.65B | -4.34% | 1,448,833 | 450.91M |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 6.55B | 1.04% | 518,110 | 618.07M |
| 146 | BLTE | Belite Bio, Inc | 6.55B | -0.39% | 96,281 | - |
| 147 | LNTH | Lantheus Holdings, Inc. | 6.54B | -0.64% | 3,073,635 | 1.56B |
| 148 | COGT | Cogent Biosciences, Inc. | 6.49B | -1.24% | 1,151,059 | - |
| 149 | DNTH | Dianthus Therapeutics, Inc. | 6.46B | 0.59% | 464,287 | 1.90M |
| 150 | HIMS | Hims & Hers Health, Inc. | 6.39B | -4.26% | 7,932,262 | 2.58B |
| 151 | ERAS | Erasca, Inc. | 6.33B | -0.98% | 1,922,595 | - |
| 152 | DFTX | Definium Therapeutics, Inc. | 6.21B | 2.03% | 2,009,160 | - |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.20B | 0.39% | 367,329 | 840.85M |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 6.12B | 1.31% | 914,929 | 7.50M |
| 155 | BLCO | Bausch + Lomb Corporation | 6.09B | 0.24% | 429,478 | 5.32B |
| 156 | PTCT | PTC Therapeutics, Inc. | 6.06B | -0.34% | 731,633 | 1.01B |
| 157 | TVTX | Travere Therapeutics, Inc. | 6.02B | 0.58% | 884,907 | 591.33M |
| 158 | CAI | Caris Life Sciences, Inc. | 5.93B | -3.05% | 3,598,261 | 989.61M |
| 159 | RDNT | RadNet, Inc. | 5.81B | -2.77% | 548,620 | 2.27B |
| 160 | AMRX | Amneal Pharmaceuticals, Inc. | 5.81B | -1.25% | 2,026,546 | 3.12B |
| 161 | STVN | Stevanato Group S.p.A. | 5.79B | -0.28% | 477,096 | 1.40B |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 5.73B | -1.43% | 247,481 | 290.54M |
| 163 | TFX | Teleflex Incorporated | 5.59B | -0.86% | 872,412 | 2.25B |
| 164 | MMED | MiniMed Group, Inc. | 5.44B | -0.87% | 1,501,753 | 3.10B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.33B | -0.52% | 874,289 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.28B | -1.54% | 2,463,014 | 1.22B |
| 167 | ACAD | ACADIA Pharmaceuticals Inc. | 5.20B | 4.03% | 2,053,505 | 1.14B |
| 168 | CRSP | CRISPR Therapeutics AG | 5.12B | -2.41% | 1,313,928 | 13.39M |
| 169 | PBLS | Parabilis Medicines, Inc. | 4.86B | 5.72% | 639,143 | 148.00K |
| 170 | DYN | Dyne Therapeutics, Inc. | 4.86B | -0.57% | 1,900,740 | - |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.79B | 0.16% | 1,519,184 | - |
| 172 | HAE | Haemonetics Corporation | 4.76B | 15.93% | 2,305,407 | 1.35B |
| 173 | LFST | LifeStance Health Group, Inc. | 4.72B | -1.51% | 3,517,041 | 1.58B |
| 174 | WAY | Waystar Holding Corp. | 4.66B | -1.46% | 1,495,733 | 1.21B |
| 175 | INDV | Indivior Pharmaceuticals, Inc. | 4.65B | 0.90% | 2,338,564 | 1.33B |
| 176 | MANE | Veradermics, Incorporated | 4.65B | 2.86% | 464,076 | - |
| 177 | ICUI | ICU Medical, Inc. | 4.60B | 0.68% | 241,929 | 2.16B |
| 178 | CELC | Celcuity Inc. | 4.56B | 0.87% | 532,975 | - |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.52B | -0.29% | 2,227,625 | 10.35M |
| 180 | CON | Concentra Group Holdings Parent, Inc. | 4.47B | -1.35% | 894,886 | 2.29B |
| 181 | NVST | Envista Holdings Corporation | 4.47B | 0.65% | 2,819,242 | 2.86B |
| 182 | DOCS | Doximity, Inc. | 4.45B | 1.71% | 2,980,522 | 655.57M |
| 183 | ELVN | Enliven Therapeutics, Inc. | 4.40B | 0.89% | 619,313 | - |
| 184 | LIVN | LivaNova PLC | 4.40B | -1.99% | 619,120 | 1.47B |
| 185 | TNGX | Tango Therapeutics, Inc. | 4.29B | 0.59% | 2,277,936 | 53.81M |
| 186 | ITGR | Integer Holdings Corporation | 4.25B | 0.01% | 761,328 | 1.84B |
| 187 | LEGN | Legend Biotech Corporation | 4.24B | 6.15% | 3,643,356 | 1.27B |
| 188 | BLLN | BillionToOne, Inc. | 4.15B | -6.30% | 526,442 | 397.41M |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.06B | 1.28% | 43,113 | 803.79M |
| 190 | HTFL | HeartFlow, Inc. | 3.93B | 7.84% | 4,169,736 | 212.07M |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 3.92B | -0.85% | 1,878,377 | 308.08M |
| 192 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.91B | 63.84% | 23,980,272 | -665.00K |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.89B | -0.77% | 1,194,076 | - |
| 194 | DNLI | Denali Therapeutics Inc. | 3.89B | -0.16% | 1,099,616 | 3.60M |
| 195 | GPCR | Structure Therapeutics Inc. | 3.82B | -0.43% | 687,395 | - |
| 196 | IRTC | iRhythm Holdings, Inc. | 3.80B | -1.44% | 570,577 | 825.34M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.76B | -0.17% | 896,392 | 117.00M |
| 198 | NHC | National HealthCare Corporation | 3.67B | 2.62% | 95,942 | 1.56B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.66B | 3.80% | 629,485 | 234.13M |
| 200 | ABCL | AbCellera Biologics Inc. | 3.60B | -0.71% | 8,201,821 | 66.17M |
| 201 | OGN | Organon & Co. | 3.59B | -0.15% | 2,158,469 | 6.13B |
| 202 | OPCH | Option Care Health, Inc. | 3.51B | 0.17% | 2,134,262 | 5.69B |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.34B | 3.63% | 1,972,078 | 463.98M |
| 204 | QURE | uniQure N.V. | 3.29B | -1.23% | 501,341 | 18.67M |
| 205 | CLDX | Celldex Therapeutics, Inc. | 3.28B | -0.31% | 998,962 | 158.00K |
| 206 | PLSE | Pulse Biosciences, Inc. | 3.28B | -1.69% | 526,021 | 1.19M |
| 207 | VCYT | Veracyte, Inc. | 3.27B | -3.33% | 1,143,502 | 561.90M |
| 208 | NAMS | NewAmsterdam Pharma Company N.V. | 3.26B | 1.30% | 948,917 | 7.12M |
| 209 | ALMS | Alumis Inc. | 3.22B | -2.43% | 661,654 | 7.40M |
| 210 | MBX | MBX Biosciences, Inc. | 3.20B | -2.53% | 560,737 | - |
| 211 | IOVA | Iovance Biotherapeutics, Inc. | 3.18B | -0.99% | 10,499,438 | 324.97M |
| 212 | GRAL | GRAIL, Inc. | 3.17B | 1.34% | 533,097 | 165.26M |
| 213 | WRBY | Warby Parker Inc. | 3.17B | 0.04% | 2,033,733 | 911.61M |
| 214 | TMDX | TransMedics Group, Inc. | 3.14B | 2.65% | 778,302 | 668.47M |
| 215 | IMNM | Immunome, Inc. | 3.13B | 0.58% | 965,338 | 4.02M |
| 216 | TARS | Tarsus Pharmaceuticals, Inc. | 3.12B | 0.58% | 628,834 | 606.33M |
| 217 | IRON | Disc Medicine, Inc. | 3.08B | 0.19% | 337,172 | - |
| 218 | BKD | Brookdale Senior Living Inc. | 2.92B | -0.08% | 3,612,520 | 2.93B |
| 219 | ZLAB | Zai Lab Limited | 2.87B | -0.27% | 1,630,983 | 449.61M |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.85B | 1.57% | 592,240 | 830.44M |
| 221 | NRIX | Nurix Therapeutics, Inc. | 2.79B | -0.88% | 816,022 | 36.77M |
| 222 | AVAH | Aveanna Healthcare Holdings Inc. | 2.76B | -0.16% | 5,047,346 | 2.60B |
| 223 | PRVA | Privia Health Group, Inc. | 2.75B | 0.09% | 929,942 | 2.36B |
| 224 | ALHC | Alignment Healthcare, Inc. | 2.74B | -1.71% | 3,422,273 | 4.58B |
| 225 | VRDN | Viridian Therapeutics, Inc. | 2.71B | 3.64% | 1,992,628 | 71.13M |
| 226 | RGC | Regencell Bioscience Holdings Limited | 2.71B | 2.06% | 88,750 | - |
| 227 | ATAI | AtaiBeckley Inc. | 2.70B | 0.69% | 10,494,558 | 4.47M |
| 228 | AXGN | Axogen, Inc. | 2.70B | 2.12% | 975,188 | 251.17M |
| 229 | TRVI | Trevi Therapeutics, Inc. | 2.68B | 1.95% | 1,747,771 | - |
| 230 | BEAM | Beam Therapeutics Inc. | 2.66B | -1.96% | 1,195,653 | 156.04M |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.65B | 0.77% | 4,967,790 | - |
| 232 | BHC | Bausch Health Companies Inc. | 2.59B | 5.32% | 4,775,289 | 10.85B |
| 233 | ACHC | Acadia Healthcare Company, Inc. | 2.56B | -8.47% | 3,919,352 | 3.37B |
| 234 | KOD | Kodiak Sciences Inc. | 2.55B | -0.81% | 623,775 | - |
| 235 | PHVS | Pharvaris N.V. | 2.53B | 2.21% | 609,433 | - |
| 236 | NEOG | Neogen Corporation | 2.52B | -2.53% | 1,433,240 | 870.40M |
| 237 | NKTR | Nektar Therapeutics | 2.51B | 1.33% | 565,521 | 54.59M |
| 238 | RARE | Ultragenyx Pharmaceutical Inc. | 2.51B | -2.45% | 1,793,436 | 717.00M |
| 239 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.48B | -2.41% | 2,122,110 | 940.61M |
| 240 | COAG | Hemab Therapeutics Holdings, Inc. | 2.45B | -2.15% | 183,053 | - |
| 241 | NUVB | Nuvation Bio Inc. | 2.44B | 7.41% | 6,993,659 | 169.90M |
| 242 | UFPT | UFP Technologies, Inc. | 2.43B | -2.28% | 93,527 | 631.64M |
| 243 | GRDN | Guardian Pharmacy Services, Inc. | 2.42B | 0.74% | 368,951 | 1.46B |
| 244 | OCUL | Ocular Therapeutix, Inc. | 2.42B | 3.38% | 4,582,559 | 52.06M |
| 245 | PGEN | Precigen, Inc. | 2.42B | 3.05% | 4,356,334 | 85.72M |
| 246 | BFLY | Butterfly Network, Inc. | 2.40B | -0.22% | 4,619,997 | 112.14M |
| 247 | PBH | Prestige Consumer Healthcare Inc. | 2.40B | 1.06% | 489,324 | 1.10B |
| 248 | URGN | UroGen Pharma Ltd. | 2.39B | -0.45% | 823,738 | 188.73M |
| 249 | CDNA | CareDx, Inc. | 2.39B | -0.43% | 840,134 | 458.09M |
| 250 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | 2.15% | 1,100,311 | - |
| 251 | RAPP | Rapport Therapeutics, Inc. | 2.35B | 1.22% | 214,733 | 20.00M |
| 252 | ATRC | AtriCure, Inc. | 2.33B | 2.21% | 878,145 | 569.62M |
| 253 | VERA | Vera Therapeutics, Inc. | 2.33B | 2.06% | 1,033,570 | - |
| 254 | KLRA | Kailera Therapeutics, Inc. | 2.31B | -3.67% | 1,297,635 | - |
| 255 | ALMR | Alamar Biosciences, Inc. | 2.29B | 2.58% | 355,451 | 100.42M |
| 256 | WGS | GeneDx Holdings Corp. | 2.28B | -1.36% | 389,521 | 454.43M |
| 257 | VCEL | Vericel Corporation | 2.27B | 1.54% | 549,697 | 306.30M |
| 258 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 1.81% | 463,479 | 959.90M |
| 259 | CLOV | Clover Health Investments, Corp. | 2.25B | -0.94% | 3,429,890 | 2.48B |
| 260 | ESTA | Establishment Labs Holdings Inc. | 2.24B | -1.83% | 325,514 | 245.82M |
| 261 | HCM | HUTCHMED (China) Limited | 2.22B | 0.64% | 284,840 | 549.12M |
| 262 | XRAY | DENTSPLY SIRONA Inc. | 2.21B | -0.71% | 4,070,787 | 3.64B |
| 263 | MESO | Mesoblast Limited | 2.19B | -2.06% | 182,259 | 65.38M |
| 264 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -2.02% | 147,985 | - |
| 265 | ADUS | Addus HomeCare Corporation | 2.16B | 2.81% | 181,434 | 1.48B |
| 266 | ADMA | ADMA Biologics, Inc. | 2.14B | 2.14% | 1,369,891 | 512.28M |
| 267 | MD | Pediatrix Medical Group, Inc. | 2.11B | 0.84% | 943,160 | 1.95B |
| 268 | ZBIO | Zenas BioPharma, Inc. | 2.08B | 4.62% | 659,815 | 1.00M |
| 269 | STOK | Stoke Therapeutics, Inc. | 2.07B | 0.03% | 574,554 | 27.59M |
| 270 | NBTX | Nanobiotix S.A. | 2.07B | -2.31% | 149,470 | 38.27M |
| 271 | GENB | Generate Biomedicines, Inc. | 2.06B | 2.49% | 580,499 | 26.48M |
| 272 | AGIO | Agios Pharmaceuticals, Inc. | 2.05B | 2.29% | 1,187,838 | 98.34M |
| 273 | BHVN | Biohaven Ltd. | 2.05B | -6.15% | 1,965,320 | - |
| 274 | SEPN | Septerna, Inc. | 2.04B | -0.90% | 332,879 | 98.88M |
| 275 | NEO | NeoGenomics, Inc. | 2.04B | -1.61% | 936,593 | 766.30M |
| 276 | GHRS | GH Research PLC | 2.04B | -0.82% | 238,661 | - |
| 277 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | 0.07% | 718,429 | 311.51M |
| 278 | TSHA | Taysha Gene Therapies, Inc. | 2.02B | -0.32% | 1,631,645 | 5.49M |
| 279 | NVCR | NovoCure Limited | 2.01B | -1.65% | 792,637 | 699.19M |
| 280 | ASTH | Astrana Health, Inc. | 2.00B | -1.48% | 357,970 | 3.84B |
| 281 | PGNY | Progyny, Inc. | 1.97B | 1.50% | 995,698 | 1.31B |
| 282 | DMRA | Damora Therapeutics, Inc. | 1.96B | 2.28% | 485,659 | - |
| 283 | KARD | Kardigan, Inc. | 1.96B | 1.80% | 231,073 | - |
| 284 | FBRX | Forte Biosciences, Inc. | 1.94B | -0.01% | 771,130 | - |
| 285 | CMPS | COMPASS Pathways plc | 1.92B | 1.31% | 3,271,292 | - |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.92B | 3.74% | 544,656 | 481.07M |
| 287 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | -0.88% | 1,600,161 | 1.97B |
| 288 | XNCR | Xencor, Inc. | 1.89B | 9.90% | 1,604,652 | 104.97M |
| 289 | TRLV | Trulieve Cannabis Corp. | 1.87B | 2.32% | 945,857 | 1.14B |
| 290 | LMAT | LeMaitre Vascular, Inc. | 1.86B | -1.20% | 467,848 | 262.43M |
| 291 | IMCR | Immunocore Holdings plc | 1.85B | 2.77% | 620,057 | 430.78M |
| 292 | ZYME | Zymeworks Inc. | 1.85B | 3.00% | 650,165 | 37.13M |
| 293 | SGRY | Surgery Partners, Inc. | 1.85B | -0.84% | 1,582,482 | 3.37B |
| 294 | ETON | Eton Pharmaceuticals, Inc. | 1.81B | 2.75% | 872,479 | 105.60M |
| 295 | LKFT | Lakefront Biotherapeutics NV | 1.81B | 1.71% | 329,244 | 1.13B |
| 296 | PRGO | Perrigo Company plc | 1.80B | 1.17% | 2,182,415 | 4.14B |
| 297 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 0.78% | 1,015,058 | 252.25M |
| 298 | ANAB | AnaptysBio, Inc. | 1.75B | -1.17% | 260,449 | 232.39M |
| 299 | AVLN | Avalyn Pharma Inc. | 1.72B | 1.59% | 194,792 | - |
| 300 | BRVE | Braveheart Bio, Inc. | 1.72B | -3.29% | 214,969 | - |
| 301 | BLFS | BioLife Solutions, Inc. | 1.71B | -1.44% | 390,292 | 106.69M |
| 302 | FTRE | Fortrea Holdings Inc. | 1.67B | -2.76% | 682,076 | 2.68B |
| 303 | INSP | Inspire Medical Systems, Inc. | 1.66B | 0.28% | 656,660 | 898.74M |
| 304 | RXRX | Recursion Pharmaceuticals, Inc. | 1.66B | -0.64% | 16,348,348 | 54.86M |
| 305 | TNDM | Tandem Diabetes Care, Inc. | 1.65B | 6.60% | 2,631,738 | 1.04B |
| 306 | BCAX | Bicara Therapeutics Inc. | 1.65B | -0.08% | 446,134 | - |
| 307 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | 1.14% | 286,465 | 978.38M |
| 308 | OMCL | Omnicell, Inc. | 1.64B | -0.17% | 947,786 | 1.25B |
| 309 | KMTS | Kestra Medical Technologies, Ltd. | 1.64B | 0.40% | 249,303 | 95.13M |
| 310 | AAPG | Ascentage Pharma Group International | 1.63B | - | 6,877 | 82.08M |
| 311 | NTLA | Intellia Therapeutics, Inc. | 1.63B | -4.05% | 3,178,626 | 59.51M |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.62B | 4.22% | 649,534 | 20.00M |
| 313 | XERS | Xeris Biopharma Holdings, Inc. | 1.61B | 3.87% | 2,142,019 | 335.41M |
| 314 | VIR | Vir Biotechnology, Inc. | 1.61B | 1.06% | 1,480,849 | 303.23M |
| 315 | AGL | agilon health, inc. | 1.60B | -1.51% | 336,765 | 5.92B |
| 316 | LBRX | LB Pharmaceuticals Inc | 1.57B | 5.49% | 540,387 | - |
| 317 | TRAX | First Tracks Biotherapeutics, Inc. | 1.57B | 0.64% | 724,700 | - |
| 318 | TYRA | Tyra Biosciences, Inc. | 1.55B | -0.69% | 341,494 | - |
| 319 | SLBT | SL Science Holding Limited | 1.55B | -1.45% | 17,999 | 3.27M |
| 320 | ARDT | Ardent Health, Inc. | 1.54B | 0.37% | 274,730 | 6.41B |
| 321 | INVA | Innoviva, Inc. | 1.54B | 1.38% | 628,823 | 440.00M |
| 322 | ABSI | Absci Corporation | 1.52B | -4.22% | 2,482,404 | 1.56M |
| 323 | FRNM | Freenome, Inc. | 1.52B | 3.46% | 1,549,223 | 34.24M |
| 324 | INNV | InnovAge Holding Corp. | 1.51B | 4.03% | 198,919 | 949.17M |
| 325 | HCSG | Healthcare Services Group, Inc. | 1.51B | 1.62% | 594,147 | 1.86B |
| 326 | JBIO | Jade Biosciences, Inc. | 1.50B | 0.43% | 721,657 | - |
| 327 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.49B | 1.06% | 1,715,707 | 208.78M |
| 328 | PSNL | Personalis, Inc. | 1.49B | 0.14% | 1,025,379 | 69.67M |
| 329 | HROW | Harrow, Inc. | 1.48B | 0.10% | 920,434 | 275.59M |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.48B | 3.41% | 408,726 | - |
| 331 | ENOV | Enovis Corporation | 1.48B | 3.64% | 807,503 | 2.30B |
| 332 | CNMD | CONMED Corporation | 1.48B | 0.02% | 498,560 | 1.37B |
| 333 | ATEC | Alphatec Holdings, Inc. | 1.47B | 0.85% | 1,432,174 | 815.05M |
| 334 | REPL | Replimune Group, Inc. | 1.47B | 6.49% | 2,245,163 | - |
| 335 | OMDA | Omada Health, Inc. | 1.45B | - | 577,661 | 309.76M |
| 336 | AZTA | Azenta, Inc. | 1.44B | -1.79% | 560,157 | 613.81M |
| 337 | ORIC | ORIC Pharmaceuticals, Inc. | 1.44B | 4.04% | 948,876 | - |
| 338 | ALVO | Alvotech | 1.41B | 1.80% | 675,582 | 562.04M |
| 339 | AORT | Artivion, Inc. | 1.41B | 2.05% | 846,924 | 471.47M |
| 340 | PAHC | Phibro Animal Health Corporation | 1.41B | 0.06% | 89,296 | 1.50B |
| 341 | INBX | Inhibrx Biosciences, Inc. | 1.39B | 2.84% | 311,231 | 1.30M |
| 342 | MLTX | MoonLake Immunotherapeutics | 1.39B | -0.06% | 825,733 | - |
| 343 | AKTS | Aktis Oncology, Inc. | 1.39B | 1.13% | 183,982 | 10.06M |
| 344 | VOR | Vor Biopharma Inc. | 1.38B | 1.17% | 1,006,854 | - |
| 345 | PNTG | The Pennant Group, Inc. | 1.38B | 0.56% | 185,133 | 1.10B |
| 346 | IART | Integra LifeSciences Holdings Corporation | 1.36B | -0.62% | 541,279 | 1.65B |
| 347 | SVRA | Savara Inc. | 1.36B | - | 1,510,437 | - |
| 348 | CGEM | Cullinan Therapeutics, Inc. | 1.34B | 1.21% | 595,220 | - |
| 349 | ANRO | Alto Neuroscience, Inc. | 1.34B | 1.58% | 433,913 | - |
| 350 | AMN | AMN Healthcare Services, Inc. | 1.34B | - | 402,064 | 3.43B |
| 351 | MGTX | MeiraGTx Holdings plc | 1.33B | 0.87% | 775,667 | 397.50M |
| 352 | SDGR | Schrödinger, Inc. | 1.32B | 1.55% | 841,092 | 259.04M |
| 353 | DRTS | Alpha Tau Medical Ltd. | 1.32B | 0.78% | 374,755 | - |
| 354 | MNKD | MannKind Corporation | 1.31B | 4.36% | 4,600,594 | 393.63M |
| 355 | NVAX | Novavax, Inc. | 1.31B | -1.73% | 2,015,486 | 413.80M |
| 356 | NUTX | Nutex Health Inc. | 1.29B | -0.40% | 127,777 | 846.72M |
| 357 | SPTX | Seaport Therapeutics, Inc. | 1.28B | -1.76% | 120,487 | - |
| 358 | GLUE | Monte Rosa Therapeutics, Inc. | 1.28B | -2.28% | 1,131,846 | 28.73M |
| 359 | APMD | Apnimed, Inc. | 1.27B | -2.27% | 347,945 | 120.15M |
| 360 | LTGO | Latigo Biotherapeutics, Inc. | 1.26B | 3.63% | 254,994 | - |
| 361 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | -0.54% | 635,372 | - |
| 362 | GDRX | GoodRx Holdings, Inc. | 1.25B | -1.88% | 1,089,952 | 785.23M |
| 363 | OMER | Omeros Corporation | 1.24B | -0.98% | 1,234,652 | 38.42M |
| 364 | IMTX | Immatics N.V. | 1.24B | -1.73% | 995,018 | 47.65M |
| 365 | STAA | STAAR Surgical Company | 1.24B | 2.28% | 928,449 | 339.59M |
| 366 | CERT | Certara, Inc. | 1.22B | 0.12% | 1,940,532 | 421.75M |
| 367 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | 1.09% | 819,530 | 337.34M |
| 368 | BVS | Bioventus Inc. | 1.20B | 3.03% | 600,966 | 581.85M |
| 369 | CRON | Cronos Group Inc. | 1.18B | 1.90% | 1,047,641 | 179.09M |
| 370 | TDOC | Teladoc Health, Inc. | 1.18B | -1.07% | 4,230,517 | 2.49B |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.17B | -0.34% | 132,821 | 804.27M |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 1.15B | 1.52% | 394,296 | 1.04B |
| 373 | IRMD | IRADIMED CORPORATION | 1.12B | -0.53% | 66,903 | 86.34M |
| 374 | KURA | Kura Oncology, Inc. | 1.10B | 9.31% | 4,086,892 | 77.23M |
| 375 | GMRS | GMR Solutions Inc. | 1.10B | 1.95% | 651,276 | 5.88B |
| 376 | SANA | Sana Biotechnology, Inc. | 1.09B | -1.36% | 2,102,866 | - |
| 377 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.08B | 3.42% | 2,904,994 | 41.47M |
| 378 | IVA | Inventiva S.A. | 1.07B | -1.28% | 770,559 | 7.94M |
| 379 | AVTX | Avalo Therapeutics, Inc. | 1.06B | -1.20% | 1,069,177 | 59.00K |
| 380 | ODTX | Odyssey Therapeutics, Inc. | 1.05B | 5.23% | 188,755 | 99.00K |
| 381 | WVE | Wave Life Sciences, Inc. | 1.04B | 3.93% | 3,496,208 | 65.37M |
| 382 | JANX | Janux Therapeutics, Inc. | 1.04B | 4.31% | 583,180 | 24.00M |
| 383 | OPK | OPKO Health, Inc. | 1.02B | - | 1,602,443 | 587.90M |
| 384 | ANNX | Annexon, Inc. | 1.00B | 2.92% | 2,244,310 | - |
| 385 | ATTO | Attovia Therapeutics, Inc. | 999.99M | 2.33% | 181,574 | 1.35M |
| 386 | CLYM | Climb Bio, Inc. | 998.82M | -0.29% | 1,159,760 | - |
| 387 | GERN | Geron Corporation | 982.98M | - | 4,242,479 | 204.56M |
| 388 | ARDX | Ardelyx, Inc. | 976.82M | -3.45% | 4,041,484 | 450.89M |
| 389 | SLDB | Solid Biosciences Inc. | 973.61M | -0.22% | 536,331 | - |
| 390 | ABUS | Arbutus Biopharma Corporation | 957.58M | 2.76% | 1,446,205 | 181.72M |
| 391 | PCRX | Pacira BioSciences, Inc. | 956.69M | 3.27% | 443,569 | 746.16M |
| 392 | DSGN | Design Therapeutics, Inc. | 955.62M | 1.13% | 917,958 | - |
| 393 | AVR | Anteris Technologies Global Corp. | 933.65M | 1.70% | 720,898 | 2.24M |
| 394 | OLMA | Olema Pharmaceuticals, Inc. | 931.85M | -1.11% | 960,519 | - |
| 395 | CBLL | CeriBell, Inc. | 929.13M | -0.78% | 450,191 | 101.96M |
| 396 | ACRS | Aclaris Therapeutics, Inc. | 928.09M | 6.50% | 2,012,740 | 8.22M |
| 397 | COLL | Collegium Pharmaceutical, Inc. | 927.83M | 1.53% | 800,213 | 808.21M |
| 398 | CADL | Candel Therapeutics, Inc. | 922.05M | -0.90% | 786,871 | - |
| 399 | QDEL | QuidelOrtho Corporation | 920.97M | -7.89% | 1,378,643 | 2.67B |
| 400 | ANL | Adlai Nortye Ltd. | 911.87M | 6.15% | 184,413 | 18.06M |
| 401 | AMPH | Amphastar Pharmaceuticals, Inc. | 907.76M | 2.30% | 411,880 | 730.02M |
| 402 | AHG | Akso Health Group | 895.26M | -13.64% | 166,253 | 13.83M |
| 403 | CSTL | Castle Biosciences, Inc. | 886.85M | -3.07% | 596,610 | 357.28M |
| 404 | TBPH | Theravance Biopharma, Inc. | 880.02M | 0.18% | 266,960 | 104.31M |
| 405 | DBVT | DBV Technologies S.A. | 871.61M | -1.36% | 164,322 | 5.04M |
| 406 | OBX | Obsidian Therapeutics, Inc. | 864.36M | 13.74% | 112,274 | - |
| 407 | SGP | SpyGlass Pharma, Inc. | 864.30M | 0.23% | 61,017 | - |
| 408 | INMD | InMode Ltd. | 861.64M | -0.20% | 375,898 | 374.63M |
| 409 | SIBN | SI-BONE, Inc. | 857.83M | 2.41% | 499,054 | 213.60M |
| 410 | BBNX | Beta Bionics, Inc. | 855.70M | 8.31% | 1,975,998 | 119.01M |
| 411 | FTH | Faeth Therapeutics, Inc. | 852.73M | 0.70% | 335,931 | - |
| 412 | SLN | Silence Therapeutics plc | 848.95M | -1.74% | 1,487,597 | 615.00K |
| 413 | AURA | Aura Biosciences, Inc. | 846.23M | 6.25% | 680,487 | - |
| 414 | IMMX | Immix Biopharma, Inc. | 844.88M | 4.14% | 1,352,755 | - |
| 415 | GLAS | Glass House Brands Inc. | 839.43M | -3.41% | 284,871 | 177.68M |
| 416 | HSTM | HealthStream, Inc. | 833.63M | 1.75% | 173,480 | 321.12M |
| 417 | RIGL | Rigel Pharmaceuticals, Inc. | 814.82M | 2.76% | 267,317 | 276.79M |
| 418 | DRUG | Bright Minds Biosciences Inc. | 814.40M | 5.74% | 128,033 | - |
| 419 | OCS | Oculis Holding AG | 814.25M | 0.38% | 198,866 | 1.45M |
| 420 | PHAR | Pharming Group N.V. | 813.90M | 1.02% | 22,013 | 366.48M |
| 421 | FDMT | 4D Molecular Therapeutics, Inc. | 813.19M | 1.17% | 2,320,208 | 92.01M |
| 422 | MNPR | Monopar Therapeutics Inc. | 799.08M | 2.20% | 143,386 | - |
| 423 | VREX | Varex Imaging Corporation | 778.05M | - | 642,497 | 865.00M |
| 424 | AHCO | AdaptHealth Corp. | 776.44M | 0.17% | 3,159,126 | 3.36B |
| 425 | ACHV | Achieve Life Sciences, Inc. | 773.83M | 0.27% | 1,064,174 | - |
| 426 | STTK | Shattuck Labs, Inc. | 747.71M | 0.81% | 517,148 | 1.00M |
| 427 | SSII | SS Innovations International, Inc. | 743.43M | -1.33% | 35,971 | 52.40M |
| 428 | GYRE | Gyre Therapeutics, Inc. | 740.12M | 2.50% | 49,594 | 109.82M |
| 429 | CTMX | CytomX Therapeutics, Inc. | 738.68M | -1.74% | 2,456,722 | 18.30M |
| 430 | PHAT | Phathom Pharmaceuticals, Inc. | 734.73M | -0.32% | 976,462 | 239.66M |
| 431 | RGNX | REGENXBIO Inc. | 730.77M | -2.29% | 623,930 | 174.48M |
| 432 | HELP | Cybin Inc. | 723.35M | 0.86% | 994,055 | - |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 717.56M | -1.00% | 446,874 | - |
| 434 | TECX | Tectonic Therapeutic, Inc. | 715.70M | 8.15% | 453,316 | - |
| 435 | CBIO | Crescent Biopharma, Inc. | 714.35M | -4.52% | 169,606 | 11.88M |
| 436 | NGNE | Neurogene Inc. | 713.81M | -2.75% | 88,444 | 925.00K |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 712.18M | -1.15% | 1,411,493 | 389.32M |
| 438 | PHR | Phreesia, Inc. | 707.13M | -1.21% | 1,612,687 | 495.59M |
| 439 | ALLO | Allogene Therapeutics, Inc. | 701.35M | -2.40% | 4,088,803 | 4.64M |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 687.07M | 0.35% | 911,556 | 136.07M |
| 441 | EVO | Evotec SE | 683.26M | -2.55% | 21,856 | 819.47M |
| 442 | NVCT | Nuvectis Pharma, Inc. | 681.28M | 9.59% | 217,870 | - |
| 443 | AGMB | AgomAb Therapeutics NV | 676.17M | 0.37% | 30,867 | - |
| 444 | VSTM | Verastem, Inc. | 672.89M | 3.48% | 2,924,318 | 87.53M |
| 445 | KIDS | OrthoPediatrics Corp. | 665.80M | 3.24% | 206,277 | 252.72M |
| 446 | SGMT | Sagimet Biosciences Inc. | 657.64M | 1.44% | 980,519 | - |
| 447 | ASMB | Assembly Biosciences, Inc. | 654.19M | 7.06% | 484,814 | 74.85M |
| 448 | ANGO | AngioDynamics, Inc. | 653.88M | 0.96% | 335,656 | 320.17M |
| 449 | STLN | Starling Oncology, Inc. | 652.26M | 1.43% | 927,187 | 587.24M |
| 450 | SOPH | SOPHiA GENETICS SA | 648.67M | -0.13% | 444,823 | 86.17M |
| 451 | VALN | Valneva SE | 647.09M | -2.69% | 60,809 | 163.30M |
| 452 | CRMD | CorMedix Inc. | 636.81M | 6.52% | 2,033,423 | 462.25M |
| 453 | MDXG | MiMedx Group, Inc. | 632.60M | 3.58% | 1,220,148 | 355.17M |
| 454 | EIKN | Eikon Therapeutics, Inc. | 631.02M | 11.27% | 747,843 | - |
| 455 | SPRY | ARS Pharmaceuticals, Inc. | 626.52M | 0.96% | 1,945,328 | 116.93M |
| 456 | AUTL | Autolus Therapeutics plc | 609.51M | 0.44% | 3,363,410 | 117.39M |
| 457 | CTKB | Cytek Biosciences, Inc. | 607.02M | -1.48% | 713,316 | 206.71M |
| 458 | TLRY | Tilray Brands, Inc. | 606.20M | -0.22% | 2,792,980 | 915.45M |
| 459 | ARVN | Arvinas, Inc. | 605.48M | 0.65% | 554,728 | 316.70M |
| 460 | CTEV | Claritev Corporation | 603.33M | 0.71% | 107,224 | 994.67M |
| 461 | BWAY | BrainsWay Ltd. | 595.24M | -5.36% | 113,122 | 60.70M |
| 462 | PRLD | Prelude Therapeutics Incorporated | 592.22M | 2.13% | 268,552 | 22.42M |
| 463 | DCTH | Delcath Systems, Inc. | 585.02M | -1.11% | 481,601 | 95.42M |
| 464 | WEAV | Weave Communications, Inc. | 582.39M | 31.65% | 49,373,160 | 257.79M |
| 465 | ALT | Altimmune, Inc. | 577.72M | -1.00% | 2,472,114 | 31.00K |
| 466 | ARTV | Artiva Biotherapeutics, Inc. | 571.04M | -0.51% | 261,930 | 251.00K |
| 467 | OABI | OmniAb, Inc. | 569.93M | 2.62% | 3,247,822 | 38.46M |
| 468 | CERS | Cerus Corporation | 556.21M | -7.07% | 2,546,442 | 221.55M |
| 469 | OVID | Ovid Therapeutics Inc. | 554.65M | -1.73% | 1,935,255 | 1.58M |
| 470 | ZURA | Zura Bio Limited | 552.93M | 1.58% | 909,325 | - |
| 471 | MPLT | MapLight Therapeutics, Inc. | 548.19M | 5.07% | 547,828 | - |
| 472 | CTNM | Contineum Therapeutics, Inc. | 545.51M | -0.21% | 531,008 | - |
| 473 | PRME | Prime Medicine, Inc. | 542.61M | -3.79% | 1,270,981 | 4.07M |
| 474 | AQST | Aquestive Therapeutics, Inc. | 542.21M | 0.70% | 5,455,979 | 54.09M |
| 475 | EOLS | Evolus, Inc. | 540.29M | 5.28% | 710,440 | 316.49M |
| 476 | TCMD | Tactile Systems Technology, Inc. | 540.26M | -3.01% | 729,987 | 350.31M |
| 477 | KYTX | Kyverna Therapeutics, Inc. | 525.67M | -5.03% | 851,457 | - |
| 478 | EVH | Evolent Health, Inc. | 517.81M | 3.85% | 3,477,396 | 2.10B |
| 479 | RLMD | Relmada Therapeutics, Inc. | 517.35M | 1.68% | 751,700 | - |
| 480 | EVMN | Evommune, Inc. | 516.07M | -0.21% | 322,426 | 10.00M |
| 481 | CCCC | C4 Therapeutics, Inc. | 514.25M | -1.99% | 2,878,764 | 35.04M |
| 482 | SCTX | Scribe Therapeutics Inc. | 511.41M | 27.94% | 507,364 | 36.28M |
| 483 | FLGT | Fulgent Genetics, Inc. | 510.96M | -0.48% | 167,973 | 323.93M |
| 484 | SRTA | Strata Critical Medical, Inc. | 504.26M | -3.39% | 896,097 | 255.98M |
| 485 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 486 | ENTX | Entera Bio Ltd. | 500.38M | -0.34% | 261,718 | 42.00K |
| 487 | NPCE | NeuroPace, Inc. | 496.67M | 1.33% | 140,669 | 106.99M |
| 488 | CABA | Cabaletta Bio, Inc. | 493.38M | 0.69% | 6,981,677 | - |
| 489 | BLSM | BlossomHill Therapeutics, Inc. | 493.36M | -1.71% | 308,067 | - |
| 490 | NRC | NRC Health | 486.85M | 1.10% | 111,083 | 140.00M |
| 491 | RZLT | Rezolute, Inc. | 486.82M | -0.43% | 912,779 | - |
| 492 | BIOA | BioAge Labs, Inc. | 480.08M | 0.58% | 478,458 | 10.36M |
| 493 | PBYI | Puma Biotechnology, Inc. | 476.97M | 4.76% | 244,699 | 231.24M |
| 494 | EYPT | EyePoint, Inc. | 471.58M | 12.32% | 16,238,028 | 2.79M |
| 495 | CLPT | ClearPoint Neuro, Inc. | 463.05M | -2.06% | 253,074 | 42.28M |
| 496 | SENS | Senseonics Holdings, Inc. | 459.48M | 8.22% | 1,199,341 | 48.55M |
| 497 | QTTB | Q32 Bio Inc. | 455.18M | -4.14% | 319,355 | 53.74M |
| 498 | OCGN | Ocugen, Inc. | 454.41M | -2.55% | 2,527,228 | 4.58M |
| 499 | SGHT | Sight Sciences, Inc. | 452.82M | -0.24% | 300,453 | 83.38M |
| 500 | EPRX | Eupraxia Pharmaceuticals Inc. | 450.72M | 0.44% | 379,171 | - |